Association between intracellular infectious agents and schizophrenia

Clinical Psychopharmacology and Neuroscience

Volumn 10, Issue 2, 2012, Pages 117-123

  Park, Mi Hee ^a   Kwon, Young Joon ^a   Jeong, Hee Yeun ^a   Lee, Hwa Young ^a   Hwangbo, Young ^a   Yoon, Hee Jung ^b   Shim, Se Hoon ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Eulji University   (South Korea)

Author keywords

Chlamydia pneumoniae; Chlamydia trachomatis; Schizophrenia; Toxoplasma

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL PNEUMONIA; CHLAMYDIASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SCHOOL CHILD; SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 84865808944     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2012.10.2.117     Document Type: Article

References (26)

1. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006;32:200-202.
2. Fuller Torrey E, Yolken RH. Familial and genetic mechanisms in schizophrenia. Brain Res Brain Res Rev 2000;31:113-117. (Pubitemid 30136167)
3. Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 2006;114:40-48. (Pubitemid 43885484)
4. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007;33:729-736. (Pubitemid 47343710)
5. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965-1976. (Pubitemid 38759657)
6. Estran C, Brenier-Pinchart MP, Pelletier L, Cesbron-Delauw MF, Pelloux H. Toxoplasma gondii in human astrocytes in vitro: interleukin (IL)-12 and IL-10 do not influence cystogenesis. J Parasitol 2006;92:1108-1110. (Pubitemid 44863069)
7. Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 2008;13:470-479. (Pubitemid 351556038)
8. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005;162:767-773. (Pubitemid 40489141)
9. Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS. Selected infectious agents and risk of schizophrenia among U.S. Military personnel. Am J Psychiatry 2008;165:99-106. (Pubitemid 351704558)
10. Phee SS, Park H, Park MC. Antibody titers of Toxoplasma gondii among patients with mental disorders. J Wonkwang Med Sci 1999;15:33-42.
11. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999;49 Pt 2:415-440.
12. Kaur C, Dheen ST, Ling EA. From blood to brain: amoeboid microglial cell, a nascent macrophage and its functions in developing brain. Acta Pharmacol Sin 2007;28:1087-1096. (Pubitemid 47197788)
13. Fellerhoff B, Laumbacher B, Wank R. High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. Med Hypotheses 2005;65:243-252. (Pubitemid 40744749)
14. Fellerhoff B, Wank R. Increased prevalence of Chlamydophila DNA in post-mortem brain frontal cortex from patients with schizophrenia. Schizophr Res 2011;129:191-195.
15. Frykholm BO. On the question of infectious aetiologies for multiple sclerosis, schizophrenia and the chronic fatigue syndrome and their treatment with antibiotics. Med Hypotheses 2009;72:736-739.
16. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276. (Pubitemid 18039085)
17. Kim CY. Psychiatric assessment instruments. 1st ed. Seoul: Hana Medical Press;2001. p.61-62.
18. Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis 2001;32:842-844. (Pubitemid 32221950)
19. Krause D, Matz J, Weidinger E, Wagner J, Wildenauer A, Obermeier M, et al. The association of infectious agents and schizophrenia. World J Biol Psychiatry 2010;11:739-743.
20. Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol 1998;36:3426-3428. (Pubitemid 28476214)
21. Haynes BF, Fauci AS. Introduction to the immune system. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., editors. Harrison's principles of internal medicine. 16th ed. New York:McGraw Hill;2005. p.1907-1930.
22. Brown AS, Vinogradov S, Kremen WS, Poole JH, Deicken RF, Penner JD, et al. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry 2009;166:683-690.
23. Miüller N, Schwarz MJ. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl 2007;(72):269-280.
24. Hariri AG, Karadag F, Gurol DT, Aksoy UM, Tezcan AE. Sexual problems in a sample of the Turkish psychiatric population. Compr Psychiatry 2009;50:353-360.
25. Myint AM, Schwarz MJ, Steinbusch HW, Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis 2009;24:55-68.
26. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006;39(Suppl 1):S10-S14. (Pubitemid 43357100)